2003 10-12

Nov. 24, 2003, the SARS Virus Detection Genechip Set, developed by CapitalBio Corporation, received the eligible certificate from National Institute for the Control of Pharmaceutical and Biological Products. We now proceed to file a Class I new drug application to the State Food and Drug Administration.